Cargando…
Risk of Meningioma in European Patients Treated With Growth Hormone in Childhood: Results From the SAGhE Cohort
CONTEXT: There has been concern that GH treatment of children might increase meningioma risk. Results of published studies have been inconsistent and limited. OBJECTIVE: To examine meningioma risks in relation to GH treatment. DESIGN: Cohort study with follow-up via cancer registries and other regis...
Autores principales: | Swerdlow, Anthony J, Cooke, Rosie, Beckers, Dominique, Butler, Gary, Carel, Jean-Claude, Cianfarani, Stefano, Clayton, Peter, Coste, Joël, Deodati, Annalisa, Ecosse, Emmanuel, Hokken-Koelega, Anita C S, Khan, Aysha J, Kiess, Wieland, Kuehni, Claudia E, Flück, Christa E, Pfaffle, Roland, Sävendahl, Lars, Sommer, Grit, Thomas, Muriel, Tidblad, Anders, Tollerfield, Sally, Zandwijken, Gladys R J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334265/ https://www.ncbi.nlm.nih.gov/pubmed/30137467 http://dx.doi.org/10.1210/jc.2018-01133 |
Ejemplares similares
-
Description of the SAGhE Cohort: A Large European Study of Mortality and Cancer Incidence Risks after Childhood Treatment with Recombinant Growth Hormone
por: Swerdlow, Anthony J, et al.
Publicado: (2015) -
How safe is growth hormone therapy? SAGhE and beyond
por: Carel, Jean-Claude
Publicado: (2013) -
The Rationale for Growth Hormone Therapy in Children with Short Stature
por: Deodati, Annalisa, et al.
Publicado: (2017) -
Epigenetics and In Utero Acquired Predisposition to Metabolic Disease
por: Deodati, Annalisa, et al.
Publicado: (2020) -
Perspectives of the European Society of Endocrinology (ESE) and the European Society of Paediatric Endocrinology (ESPE) on rare endocrine disease
por: Reincke, Martin, et al.
Publicado: (2021)